The clinical study is conducted in patients with recurrent epithelian cancer, primary peritoneal cancer or fallopian tube cancer.
At the end of 2011, successful database lock was performed. We are very pleased to meet this important milestone for our client’s clinical development program. In this study we are responsible for
We will continue to support our client’s clinical program to defeat ovarian cancer. Patients’ enrollment will continue until 650 patients are enrolled.
Ovarian cancer is a disease with few and unspecific symptoms at its early stages, therefore difficult to detect. Unlike certain other cancer diseases the number of patients diagnosed with ovarian cancer increases every year. Ovarian cancer is most often diagnosed in women over 50 years of age, but younger women are also affected. The annual incidence of new diagnosed cases is approximately 125 000 women in EU alone.